These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 12396541

  • 1. Successful discontinuation of fluconazole as secondary prophylaxis for cryptococcosis in AIDS patients responding to highly active antiretroviral therapy.
    Sheng WH, Hung CC, Chen MY, Hsieh SM, Chang SC.
    Int J STD AIDS; 2002 Oct; 13(10):702-5. PubMed ID: 12396541
    [Abstract] [Full Text] [Related]

  • 2. [Successful discontinuation of antifungal secondary prophylaxis in AIDS-related cryptococcosis].
    Negroni R, Helou SH, López Daneri G, Robles AM, Arechavala AI, Bianchi MH.
    Rev Argent Microbiol; 2004 Oct; 36(3):113-7. PubMed ID: 15559192
    [Abstract] [Full Text] [Related]

  • 3. A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy.
    Aberg JA, Price RW, Heeren DM, Bredt B.
    J Infect Dis; 2002 Apr 15; 185(8):1179-82. PubMed ID: 11930330
    [Abstract] [Full Text] [Related]

  • 4. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.
    Lortholary O, Poizat G, Zeller V, Neuville S, Boibieux A, Alvarez M, Dellamonica P, Botterel F, Dromer F, Chêne G.
    AIDS; 2006 Nov 14; 20(17):2183-91. PubMed ID: 17086058
    [Abstract] [Full Text] [Related]

  • 5. [Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients].
    Metta HA, Corti ME, Negroni R, Helou S, Arechavala A, Soto I, Villafañe MF, Muzzio E, Castello T, Esquivel P, Trione N.
    Rev Argent Microbiol; 2002 Nov 14; 34(3):117-23. PubMed ID: 12415893
    [Abstract] [Full Text] [Related]

  • 6. Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature.
    Skiest DJ, Hester LJ, Hardy RD.
    J Infect; 2005 Dec 14; 51(5):e289-97. PubMed ID: 16321643
    [Abstract] [Full Text] [Related]

  • 7. Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active anti-retroviral therapy.
    Sun HY, Chen MY, Hsiao CF, Hsieh SM, Hung CC, Chang SC.
    Clin Microbiol Infect; 2006 Apr 14; 12(4):381-8. PubMed ID: 16524416
    [Abstract] [Full Text] [Related]

  • 8. AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy.
    Antinori S, Ridolfo A, Fasan M, Magni C, Galimberti L, Milazzo L, Sollima S, Adorni F, Giuliani G, Galli M, Corbellino M, Parravicini C.
    HIV Med; 2009 Jan 14; 10(1):6-11. PubMed ID: 19125961
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cessation of secondary prophylaxis in patients with cryptococcosis.
    Nwokolo NC, Fisher M, Gazzard BG, Nelson MR.
    AIDS; 2001 Jul 27; 15(11):1438-9. PubMed ID: 11504967
    [Abstract] [Full Text] [Related]

  • 11. Monitoring of human cytomegalovirus (HCMV)-specific CD4+ T cell frequency by cytokine flow cytometry as a possible indicator for discontinuation of HCMV secondary prophylaxis in HAART-treated AIDS patients.
    Lilleri D, Piccinini G, Genini E, Comolli G, Chiesa A, Tordato F, Sotgiu G, Parisi A, Baldanti F, Revello MG, Gerna G.
    J Clin Virol; 2004 Apr 27; 29(4):297-307. PubMed ID: 15018859
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis.
    Zeller V, Truffot C, Agher R, Bossi P, Tubiana R, Caumes E, Jouan M, Bricaire F, Katlama C.
    Clin Infect Dis; 2002 Mar 01; 34(5):662-7. PubMed ID: 11810599
    [Abstract] [Full Text] [Related]

  • 14. Prevention of cryptococcosis in HIV-infected patients with limited access to highly active antiretroviral therapy: evidence for primary azole prophylaxis.
    Cantey PT, Stephens DS, Rimland D.
    HIV Med; 2005 Jul 01; 6(4):253-9. PubMed ID: 16011530
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.
    Mussini C, Pezzotti P, Miró JM, Martinez E, de Quiros JC, Cinque P, Borghi V, Bedini A, Domingo P, Cahn P, Bossi P, de Luca A, d'Arminio Monforte A, Nelson M, Nwokolo N, Helou S, Negroni R, Jacchetti G, Antinori S, Lazzarin A, Cossarizza A, Esposito R, Antinori A, Aberg JA, International Working Group on Cryptococcosis.
    Clin Infect Dis; 2004 Feb 15; 38(4):565-71. PubMed ID: 14765351
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term follow-up of asymptomatic HIV-infected patients who discontinued antiretroviral therapy.
    Fernández Guerrero ML, Rivas P, Molina M, Garcia R, De Górgolas M.
    Clin Infect Dis; 2005 Aug 01; 41(3):390-4. PubMed ID: 16007538
    [Abstract] [Full Text] [Related]

  • 19. Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.
    Madec Y, Laureillard D, Pinoges L, Fernandez M, Prak N, Ngeth C, Moeung S, Song S, Balkan S, Ferradini L, Quillet C, Fontanet A.
    AIDS; 2007 Jan 30; 21(3):351-9. PubMed ID: 17255742
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.